We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients reported reduced symptoms of dry eye for 12 ...

Please provide your email address to receive an email when new articles are posted on . LipiFlow has consistently demonstrated safety and efficacy in treating meibomian gland dysfunction. The review ...

Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...

Meibomian gland dysfunction, an etiological factor of dry eye disease, showed promising results in response to treatment with intense pulsed light. A review published in Clinical Ophthalmology found ...

A research team from Peking Union Medical College Hospital and Tsinghua University has developed a compact optical AI chip ...

Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Three weeks of oral azithromycin seems to be equivalent to six weeks of doxycycline for treatment of severe meibomian gland dysfunction (MGD), according to a study published online March 23 in JAMA ...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular ...

A trio of studies from the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting show the potential of several emerging treatments for dry eye disease.

Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...